Tag: Matthew Holt
-
FDA Approves Web-CBT for IBS; GET/CBT as Tomorrow’s “Rubbish”
Mahana set to announce FDA approval for ineffective IBS program Earlier this year, I spent a lot of time blogging about the unethical and dishonest manner in which a San Francisco start-up called Mahana Therapeutics was promoting an eight-week web-based program of cognitive behavior therapy for patients suffering from irritable bowel syndrome. The company had…